TCN2 and multiple sclerosis: For example,Jonnalagadda et al. [22] reported that neuroinflammation suppressed theVitB12-transcobalamin 2-CD320 pathway in an animal model of multiple sclerosis,and fingolimod, a therapeutic agent for multiple sclerosis, exerted itsanti-inflammatory effects via restoring this pathway.